OCEL लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (5 Mar 2024 @ 01:44):
Our systems believe the stock currently is undervalued by 0.24% compare to its pairs and should correct upwards.

Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases...

Stats
आज की मात्रा	4 735
औसत मात्रा	4 716
बाजार मूल्य	19.97M
EPS	$-0.150 ( Q4 \| 2024-01-29 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.567 (Sector) 0 (Industry) 0
ATR14	$0 (0.00%)

ACUT 16.78%

AIMD -3.89%

AKABY 0.00%

AOBI 0.00%

ARNI 417.24%

BETRF 0.00%

BRAXF 7.14%

BVNRY -7.81%

CLVLY -2.39%

COEP 1.05%

CPMV 0.00%

CRXM 0.00%

CSLLY 0.20%

ERGO 0.00%

GSTC 0.00%

IPCIF 0.00%

LVCLY 0.00%

MLCT 2.63%

NPTX 0.00%

NUGX 0.00%

OBMP -37.10%

OCEL -0.27%

ODTC 0.00%

OTLC 6.45%

PFND 0.00%

PROT 0.00%

PVCT 1.11%

QSAM -99.95%

RGBP 10.45%

RGBPP 0.00%

RSPI 8.11%

SIGY 0.00%

SILO 1.01%

SKYE 10.33%

SNNAQ 0.00%

SPHRY 0.00%

UCBJY 0.39%

USRM 0.00%

VGLS 100.00%

VICP 59.29%

WXXWY -1.02%

Insider Trading

Date	Person	Action	Amount	type
2023-06-29	Leider Harry L.	Buy	500 000	Common Stock
2023-06-28	Leider Harry L.	Buy	549 450	Common Stock
2023-12-19	Leider Harry L.	Sell	5 248	Common Stock
2023-07-07	Skycrest Holdings, Llc	Buy	320 710	Common Stock
2023-06-29	Skycrest Holdings, Llc	Buy	200 000	Common Stock

INSIDER POWER
-81.53
Last 93 transactions
Buy: 116 969 610 \| Sell: 385 387 546

सहसंबंध (AI algo v.1.1b): Undervalued: 0.24% $2.76 paired level. (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

Organicell Regenerative सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Organicell Regenerative वित्तीय

Annual	2023
राजस्व:	$4.56M
सकल लाभ:	$4.05M (88.86 %)
EPS:	$-0.990

FY	2023
राजस्व:	$4.56M
सकल लाभ:	$4.05M (88.86 %)
EPS:	$-0.990

FY	2022
राजस्व:	$6.49M
सकल लाभ:	$5.74M (88.39 %)
EPS:	$-1.570

FY	2021
राजस्व:	$5.60M
सकल लाभ:	$5.05M (90.21 %)
EPS:	$-0.0100

Financial Reports:

No articles found.

Organicell Regenerative Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Organicell Regenerative

Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases. Its leading product candidate is Zofin, an acellular, biologic therapeutic derived from perinatal sources and is manufactured to retain naturally occurring microRNAs without the addition or combination of any other substance or diluent, which is in Phase I/II clinical trial to treat COVID-19. The company also provides independent education, advertising, and marketing services to medical and other healthcare, anti-aging, and regenerative service providers. It has a research and development agreement with the Centers for Disease Control and Prevention to determine the anti-inflammatory and anti-infective effectiveness of Zofin in experimental models of influenza infection; and an agreement with Oklahoma State University to evaluate Zofin for the treatment of respiratory diseases caused by virus infections of pandemic potential. The company was formerly known as Biotech Products Services and Research, Inc. and changed its name to Organicell Regenerative Medicine, Inc. in June 2018. Organicell Regenerative Medicine, Inc. was incorporated in 2011 and is headquartered in Miami, Florida.